What Happens in the Room Where Biopharma Deals Happen

Dec. 10, 2021 - 33 minutes 34 seconds

This article was originally published on Cowen.com

In this episode of TD Cowen’s Biotech Decoded Podcast Series, Devang Bhuva, Senior Vice President, Corporate Development and Alliance Management at Gilead speaks with Yaron Werber, M.D., Biotechnology Analyst. They share an inside look at the deal-making process from start to finish. They discuss how deals get done, trends in oncology M&A, the framework that potential acquirers use to triage and identify potential targets, and what happens on both sides of the negotiating table. Press play to listen to the podcast.

Subscribe to Spotify
Subscribe to Apple Podcasts

This podcast was originally recorded on December 10, 2021.


Portrait of Yaron Werber, M.D., MBA

Managing Director, Health Care – Biotechnology Research Analyst, TD Cowen

Portrait of Yaron Werber, M.D., MBA


Managing Director, Health Care – Biotechnology Research Analyst, TD Cowen

Portrait of Yaron Werber, M.D., MBA


Managing Director, Health Care – Biotechnology Research Analyst, TD Cowen

back to top